ArticleCureus2026

A Case of Dual Endocrinopathies Induced by Pembrolizumab Following Treatment for Non-small Cell Lung Cancer: Type 1 Diabetes and Hyperthyroidism/Autoimmune Thyroiditis.

Carolina Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.